This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Charles River Laboratories International In (CRL)

NYSE: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 155.93M 109.68M 68.90M 179.16M
Receivables 220.63M 206.33M 184.81M 192.97M
Inventories 89.40M 88.47M 92.97M 100.30M
Other Current Assets 750.00K 73.99M 107.00K 3.86M
Total Current Assets 552.55M 485.25M 425.84M 552.89M
Property, Plant & Equipment, Gross 1.32B 1.31B 1.29B 1.26B
Accumulated Depreciation & Depletion 645.53M 595.99M 556.64M 503.69M
Property, Plant & Equipment, Net 676.18M 717.02M 738.03M 752.66M
Intangibles 84.54M 84.92M 93.44M 121.24M
Other Non-Current Assets 65.12M 51.99M 58.64M 63.14M
Total Non-Current Assets 1.09B 1.10B 1.13B 1.18B
Liabilities & Shareholder Equity
Total Assets 1.64B 1.59B 1.56B 1.73B
Accounts Payable 31.77M 31.22M 34.33M 30.63M
Short Term Debt 21.44M 139.38M 14.76M 30.58M
Other Current Liabilities 20.70M 20.02M 11.72M 23.38M
Total Current Liabilities 247.03M 342.25M 216.80M 259.78M
Long Term Debt 642.35M 527.14M 703.19M 670.27M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 90.58M 113.76M 110.97M 114.60M
Minority Interest 1.32M 571.00K 411.00K -5.45M
Total Non-Current Liabilities 756.60M 643.29M 815.94M 786.17M
Total Liabilities 1.00B 985.54M 1.03B 1.05B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 640.98M 600.80M 525.58M 687.42M
Common Par 825.00K 796.00K 785.00K 775.00K
Additional Paid In Capital 2.21B 2.10B 2.06B 2.00B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -265.47M -368.30M -465.60M -575.16M
Treasury Stock -1.31B -1.14B -1.07B -768.70M
Other Equity Adjustments 5.36M 6.60M 4.59M 33.64M
Total Capitalization 1.28B 1.13B 1.23B 1.36B
Total Equity 640.98M 600.80M 525.58M 687.42M
Total Liabilities & Stock Equity 1.64B 1.59B 1.56B 1.73B
Total Common Shares Outstanding 47.55M 48.22M 48.88M 56.44M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 34.97M 31.39M 29.60M 21.09M
Basic Weighted Shares Outstanding 47.74M 47.91M 50.82M 62.56M
Diluted Weighted Shares Outstanding 48.49M 48.41M 51.32M 62.56M
Number of Employees 7700 7200 7100 7500
Number of Part-Time Employees 0 0 0 0
CRL News

CRL Charles River Laboratories International In

Analysts Ratings for CRL

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 5 5
Moderate Buy 0 0 0 0
Hold 11 11 12 11
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET CRL ANALYST REPORT

Brokerage Partners

CRL Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs